ক্যান্সার চিকিৎসার কথা

Dr. Rathindra Nath Bose - Vice President for research and dean of the Graduate College, designed and conducted the studies on the new compounds, which have successfully and safely inhibited ovarian cancer tumor progression in mice. New York based company Phosplatin Therapeutics has licensed this new drug of anti cancer compounds, that could lead to a new chemotherapy of ovarian cancer and other solid tumor.